Suptavumab Antibody
Suptavumab (REGN2222) is a human monoclonal antibody that neutralizes respiratory syncytial virus (RSV) by targeting conserved epitopes on subtypes A and B. It is a valuable research tool for studying RSV pathogenesis and evaluating antiviral strategies in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
Suptavumab, RSV, REGN2222, REGN-2222, REGN 2222
Target
RSV
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Concentration
3.15 mg/mL
Purity
96.40% (May vary between batches)
Molecular Weight
146.04 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RPU52484-01 50 µg
Recombinant Human Synaptotagmin Like Protein 2 (SYTL2)
Sign In for Pricing
View Details RPU52484-02 100 µg
Recombinant Human Synaptotagmin Like Protein 2 (SYTL2)
Sign In for Pricing
View Details RPU52484-03 1 mg
Recombinant Human Synaptotagmin Like Protein 2 (SYTL2)
Sign In for Pricing
View Details 
45709141 1x 10^6 Cells / 1.0 mL
STEAP1 CRISPR Knock Out 293T Cell Line (Human)
Sign In for Pricing
View Details 
bs-20074R-Biotin 100 µL
Phospho-CDKN1B (Ser10) Polyclonal Antibody, Biotin Conjugated
Sign In for Pricing
View Details